Abstract
Developmentally regulated changes in the immature brain may contribute to an age-related period of susceptibility to seizures and brain injury resulting from impaired brain perfusion. It is therefore crucial that immature animal models be developed that are relevant to ischemic injury in the immature brain as an important cause of neurologic morbidity. We review here the animal models for ischemic injury in the immature brain with a focus on rodent models. These models have begun to be used for neuroprotective studies. Of the findings from these pre-clinical studies, a few interventions, including hypothermia and magnesium, have been studied in clinical trials. The published results so far from these clinical studies are reviewed here as well. More pre-clinical and clinical studies are needed to assess approaches to preventing ischemic brain injury in term neonates, infants, and children.
Keywords: ischemia, stroke, immature brain, seizures, neuroprotection
Current Pediatric Reviews
Title: Neuroprotection for Ischemic Injury in the Immature Brain
Volume: 1 Issue: 2
Author(s): Anne M. Comi
Affiliation:
Keywords: ischemia, stroke, immature brain, seizures, neuroprotection
Abstract: Developmentally regulated changes in the immature brain may contribute to an age-related period of susceptibility to seizures and brain injury resulting from impaired brain perfusion. It is therefore crucial that immature animal models be developed that are relevant to ischemic injury in the immature brain as an important cause of neurologic morbidity. We review here the animal models for ischemic injury in the immature brain with a focus on rodent models. These models have begun to be used for neuroprotective studies. Of the findings from these pre-clinical studies, a few interventions, including hypothermia and magnesium, have been studied in clinical trials. The published results so far from these clinical studies are reviewed here as well. More pre-clinical and clinical studies are needed to assess approaches to preventing ischemic brain injury in term neonates, infants, and children.
Export Options
About this article
Cite this article as:
Comi M. Anne, Neuroprotection for Ischemic Injury in the Immature Brain, Current Pediatric Reviews 2005; 1 (2) . https://dx.doi.org/10.2174/1573396054065448
DOI https://dx.doi.org/10.2174/1573396054065448 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Symptomatic Improvement, Increased Life-Span and Sustained Cell Homing in Amyotrophic Lateral Sclerosis After Transplantation of Human Umbilical Cord Blood Cells Genetically Modified with Adeno-Viral Vectors Expressing a Neuro-Protective Factor and a Neural Cell Adhesion Molecule
Current Gene Therapy The Influence of Erythropoietin and Proinflammatory Cytokines in the Development of Cerebral Palsy
Vascular Disease Prevention (Discontinued) Hypertension to Heart Failure: New Developmental Strategies do not Cross a Clinical and Therapeutic Divide
Current Pharmaceutical Design Stem Cells Therapies in Basic Science and Translational Medicine: Current Status and Treatment Monitoring Strategies
Current Pharmaceutical Biotechnology Conference Report [IANR V and 9th GCNN Conference with 4th ISCITT Symposium]
CNS & Neurological Disorders - Drug Targets Regulation of Innate Immune Responses in the Central Nervous System
CNS & Neurological Disorders - Drug Targets Nucleus Accumbens Dopamine and the Forebrain Circuitry Involved in Behavioral Activation and Effort-Related Decision Making: Implications for Understanding Anergia and Psychomotor Slowing in Depression
Current Psychiatry Reviews Penetration and Effectiveness of Antiretroviral Therapy in the Central Nervous System
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Image Integration Procedures in Multisensory Medical Images: A Comprehensive Survey of the State-of-the-art Paradigms
Current Medical Imaging Cannabinoids as Neuroprotective Agents in Traumatic Brain Injury
Current Pharmaceutical Design Enhanced Tolerance against Early and Late Apoptotic Oxidative Stress in Mammalian Neurons through Nicotinamidase and Sirtuin Mediated Pathways
Current Neurovascular Research Expression and Functions of LRP-2 in Central Nervous System: Progress in Understanding its Regulation and the Potential Use for Treatment of Neurodegenerative Diseases
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Rheumatic Manifestations in Malignancy
Current Rheumatology Reviews Application of the Phage Display Technology for the Development of Peptide- mediated Drug Delivery Systems through the Blood-Brain Barrier
Current Pharmaceutical Biotechnology Persistent Pulmonary Hypertension of the Newborn: Therapeutical Approach
Mini-Reviews in Medicinal Chemistry Transport Mechanisms at the Blood-Cerebrospinal-Fluid Barrier: Role of Megalin (LRP2)
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies
Current Drug Delivery Is the Modulation of Autophagy the Future in the Treatment of Neurodegenerative Diseases?
Current Topics in Medicinal Chemistry Functional Biomarkers: an Approach to Bridge Pharmacokinetics and Pharmacodynamics in Pediatric Clinical Trials
Current Pharmaceutical Design Relationships Between Mitochondria and Neuroinflammation: Implications for Alzheimer’s Disease
Current Topics in Medicinal Chemistry